Grow your specialty business. Stay ahead of regulation.

Application engineering, formulation history and regulatory signal live in different places. ZopaAI joins them to 230,000+ external sources and grades every account on the margin you actually keep.

Book a demo30 minutes, no obligation.

Chemicals

Specialty potential and regulatory signals, in one view

Chemical sales teams often balance several things at once: growing the specialty business, supporting application projects and keeping an eye on regulatory change in their customers' markets. Much of the relevant information sits in project logs, spreadsheets or with distribution partners, which makes it hard to compare across accounts. ZopaAI connects your ERP, application project log and quote history with regulatory signals such as REACH restrictions and SVHC listings, plus data on formulators and end markets, and scores accounts on specialty potential and margin. Formulation data stays in your environment. Your application engineers can focus on the projects most likely to convert.

Frankfurter Allgemeine Zeitung
ZopaAI stands for reliable, scientifically verified AI for use in companies, in order to avoid the problem of AI hallucinations.
Frankfurter Allgemeine Zeitung
Newspaper, Frankfurt

Eight building blocks, usable on their own, together a steering system

All blocks run on the same data foundation and the same score logic. You can start with one of them without having to rebuild the others later.

View by role

Pick your role, the modules used day to day in that role are highlighted.

Regulation

Regulatory & substitution signal

A REACH restriction, an SVHC listing or a customer's own substitution programme is the moment a formulation comes under review — and you usually hear about it after the trial has started. ZopaAI tracks regulatory decisions and substitution announcements across your customers' end markets and maps them onto the formulations they buy from you, so the conversation starts while the alternative is still being chosen.

  • Regulatory changes mapped to affected customer formulations
  • Substitution pressure flagged in the customer's own end market
  • Lead time shown: quarters until the change bites
What the output looks like
“14 accounts are exposed to the upcoming restriction on two of your additive lines. In 5 cases the end customer has already announced a reformulation programme for 2027.”

Illustrative wording. Figures and names are not from a real client project.

What changed at a specialty chemicals producer in 12 months.

+21 %revenue from specialtiesfrom 34 % to 41 % of total revenue
+11 ppapplication projects that convertedfrom 42 % to 53 %
+13 ppswitch rate from standard to specialty1,300 accounts in scope

Scope of the case study

Client
Specialty chemicals producer, additives and formulationsaround 800 employees
Market
Europearound 1,300 active accountsroughly 55 % of revenue through distribution
Team
24 field sales and application engineers
Blocks in use
Application engineering allocationAccount scoringSpecialty switch potentialDistribution partner performance
Period
12 months, three wavesmeasured against control regions
Data connected
ERP customer masterapplication project logquote logregulatory sources

Full case study as a PDF

Two pages on initial situation, data foundation, methodology, results. Get access to the link.

Presented anonymised. Figures from the client's own project controlling.

We now spend application engineering time where it will pay back, not where the loudest sales rep asks for it.
Head of SalesSpecialty chemicals

Questions we hear first

Short answers before your first call.

  • Internal formulation data stays internal. ZopaAI reads it in place and returns scores, never content. Nothing leaves your environment, nothing is used to train models, and the external layer works entirely on public and licensed sources.

Book a demo

Choose your industry and time.We will match you with an expert.

Not another sales pitch, but an honest discussion focusing on your needs. 30 minutes, no sensitive data, no risk, no cost.

  • Industry lead, not a generalist
  • Valuable discussion, honest assessment.
  • Focused on discovering potentials.